Article
Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics.
Human molecular genetics - 1 Jun 2007
Camp Nicola J, Cannon-Albright Lisa A, Farnham James M, Baffoe-Bonnie Agnes B, George Asha, Powell Isaac, Bailey-Wilson Joan E, Carpten John D, Giles Graham G, Hopper John L, Severi Gianluca, English Dallas R, Foulkes William D, Maehle Lovise, Moller Pal, Eeles Ros, Easton Douglas, Badzioch Michael D, Whittemore Alice S, Oakley-Girvan Ingrid, Hsieh Chih-Lin, Dimitrov Latchezar, Xu Jianfeng, Stanford Janet L, Johanneson Bo, Deutsch Kerry, McIntosh Laura, Ostrander Elaine A, Wiley Kathleen E, Isaacs Sarah D, Walsh Patrick C, Thibodeau Stephen N, McDonnell Shannon K, Hebbring Scott, Schaid Daniel J, Lange Ethan M, Cooney Kathleen A, Tammela Teuvo L J, Schleutker Johanna, Paiss Thomas, Maier Christiane, Grönberg Henrik, Wiklund Fredrik, Emanuelsson Monica, Isaacs William B
Abstract excerpt
Previously, an analysis of 14 extended, high-risk Utah pedigrees localized in the chromosome 22q linkage region to 3.2 Mb at 22q12.3-13.1 (flanked on each side by three recombinants) contained 31 annotated genes. In this large, multi-centered, collaborative study, we performed statistical recombi...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.